Cargando…
The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects
Prostate cancer is a high-incidence cancer, often detected late in life. The prostate gland is an accessory gland that secretes citrate; an impaired citrate secretion reflects imbalances in the activity of enzymes in the TCA Cycle in mitochondria. Profiling studies on prostate tumours have identifie...
Autores principales: | Singh, Reema, Mills, Ian G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511631/ https://www.ncbi.nlm.nih.gov/pubmed/34660272 http://dx.doi.org/10.3389/fonc.2021.704353 |
Ejemplares similares
-
Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients
por: Stevens, Claire, et al.
Publicado: (2023) -
Commentary: Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients
por: Rollin, Francois G., et al.
Publicado: (2023) -
Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives
por: Detti, Beatrice, et al.
Publicado: (2022) -
The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer
por: Yu, Yina, et al.
Publicado: (2020) -
Editorial: Genomics and Epigenomics of Cancer Immunotherapy: Challenges and Clinical Implications
por: Abedalthagafi, Malak
Publicado: (2021)